Regenxbio RGNX Total costs & expenses

Total costs & expenses at other companies

Regeneron PharmaceuticalsREGN

$3B+15.5%

Sarepta Therapeutics, Inc.SRPT

$387.96M-21.7%

BiogenBIIB

$2.6B+36.9%

BioMarin PharmaceuticalsBMRN

$878.79M+60.2%

Opko HealthOPK

$170.55M-21.3%

BridgeBio PharmaBBIO

$350.76M+43.3%

FAQ

What is Regenxbio's total costs & expenses?

Regenxbio (RGNX) reported total costs & expenses of $78.76M in Q2 2026.

How has Regenxbio's total costs & expenses changed year-over-year?

Regenxbio's total costs & expenses decreased by 6.9% year-over-year, from $84.64M to $78.76M.

What is the long-term trend for Regenxbio's total costs & expenses?

Over 4 years (2021 to 2025), Regenxbio's total costs & expenses has grown at a 1.7% compound annual growth rate (CAGR), from $310.37M to $331.64M.

What does total costs & expenses mean?

This is the aggregate sum of all operating costs, including research and development, selling, general, and administrative expenses, and other operational outlays. It provides a comprehensive view of the company's total burn rate and operational footprint. Investors use this to assess the company's overall cost structure and efficiency in managing its business activities.